바이오모아 (BioMoa) — ADC · Antibody

9268프로그램 35FDA 승인

0오늘 방문

572누적 방문

8122갱신 대기 S–CData Tier S/A/B차세대 1068HER2 breast 5456Antibody 2744CGT →Psoriasis →NSCLC 35FDA 승인

피드 Data Tier 차세대

최근 활동

RSS →

ADCBiologicstalepharmaand GmbHPhase 1

Rucaparib Camsylate (Rucaparib Camsylate)

BRCA1 Gene Mutation; BRCA2 Gene Mutation · BRCA1 Gene Mutation

#BRCA1GeneMutation#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2

효능 ORR 9%임상시험 7상태 ACTIVE

AntibodystaleRochePhase 1

trastuzumab vc-seco-DUBA (SYD985, SYD985 (trastuzumab vc-seco-DUBA))

Solid Tumors · Solid Tumors

#SolidTumors#Antibody#Phase1#항체#면역항체+2

효능 ORR 27.8%임상시험 7상태 ACTIVE

AntibodystaleImmunoGen, Inc.Phase 2

Lorvotuzumab Mertansine (Lorvotuzumab Mertansine)

Pleuropulmonary Blastoma; Recurrent Malignant Peripheral Nerve Sheath Tumor · Pleuropulmonary Blastoma

#PleuropulmonaryBlastoma#Antibody#Phase2#항체#면역항체+3

효능 ORR 0.00%임상시험 7상태 ACTIVE

ADCBiologicstaleByondis B.V.Phase 2

SYD985 (SYD985)

Endometrial Cancer · Endometrial Cancer

#EndometrialCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

효능 ORR 27.8%임상시험 7상태 ACTIVE

AntibodyHoffmann-La RochePhase 3

Emactuzumab (Emactuzumab)

Cancer · Cancer

#Cancer#Antibody#Phase3#항체#면역항체+2

임상시험 7상태 RECRUITING

ADCBiologicShanghai Junshi Bioscience Co.,…Phase 2

JS212 (JS212)

Non-squamous Non-small Cell Lung Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

임상시험 7상태 RECRUITING

AntibodystaleAstraZenecaPhase 3

MEDI4736 (Durvalumab, Durvalumab (MEDI4736))

Non-small Cell Lung Cancer · Non Small Cell Lung Carcinoma NSCLC

#NonSmallCellLungCarcinomaNSCLC#Antibody#Phase3#항체#면역항체+3

효능 ORR 44%임상시험 7상태 RECRUITING

AntibodyRochePhase 3

atezolizumab (Tecentriq, Atezolizumab and Recombinant Human Hyaluronidase)

Lung Non-Small Cell Carcinoma; Stage II Lung Cancer AJCC v8 · Lung Non-Small Cell Carcinoma

#LungNon-SmallCellCarcinoma#Antibody#Phase3#항체#면역항체+3

효능 ORR 10.5%임상시험 7상태 RECRUITING

ADCBiologicstaleQuantumLeap Healthcare Collabor…Phase 2

[vic-]trastuzumab duocarmazine (SYD985, SYD985 ([vic-]trastuzumab duocarmazine))

Breast Neoplasms; Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3

효능 ORR 27.8%임상시험 7상태 RECRUITING

ADCBiologicstaleCanadian Myeloma Research GroupPhase 2

GSK2857916 with Pomalidomide and Dexamethasone (GSK2857916 with Pomalidomide and Dexamethasone)

Relapsed and/or Refractory Multiple Myeloma · FRα

#FR#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3

효능 ORR 100%임상시험 7상태 RECRUITING

ADCBiologicstaleShanghai Henlius BiotechPhase 2

HLX22 (HLX22)

HER2-low Hormone Receptor Positive Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

임상시험 7상태 RECRUITING

ADCBiologicstaleMerck Sharp & Dohme LLCPhase 2

Raludotatug deruxtecan (Raludotatug deruxtecan)

Ovarian Cancer Recurrent · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

임상시험 7상태 RECRUITING

AntibodystaleEli LillyPhase 2

Cetuximab/Erbitux (Cetuximab/Erbitux)

Cancer · Head and Neck Cancer

#HeadandNeckCancer#Antibody#Phase2#항체#면역항체+3

효능 ORR 52.2%임상시험 7상태 ACTIVE

ADCBiologicstaleSuzhou Maximum Bio-tech Co., Lt…Phase 2

MT027 (MT027)

Rare Malignant Neoplasm; Advanced Solid Tumors · Rare Malignant Neoplasm

#RareMalignantNeoplasm#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

임상시험 7상태 RECRUITING

ADCBiologicstaleQuantumLeap Healthcare Collabor…Phase 1

trastuzumab (Herceptin, SYD985, Vic-trastuzumab duocarmazine, Vic-trastuzumab duocarmazine (SYD985) + paclitaxel)

HER2-positive Breast Cancer; HER2 Low · HER2

#HER2#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3

효능 ORR 27.8%임상시험 7상태 DISCONTINUED

CGTBiologicstaleNational Heart, Lung, and Blood…Phase 2

ATLCAR.CD30 T cells (ATLCAR.CD30 T cells)

Peripheral T Cell Lymphoma · CD30

#CD30#CGT#Phase2#세포유전치료#CAR-T+3

임상시험 7상태 RECRUITING

CGTBiologicstalePersonGen BioTherapeutics (Suzh…Phase 2

anti-MUC1 CAR-T cells (anti-MUC1 CAR-T cells)

Advanced Esophageal Cancer · Malignant Glioma of Brain

#MalignantGliomaofBrain#CGT#Phase2#세포유전치료#CAR-T+3

임상시험 7상태 ACTIVE

ADCBiologicstaleConvalife (Shanghai) Co., Ltd.Phase 1

Neratinib Maleate (Neratinib Maleate)

Metastatic Malignant Solid Neoplasm; Unresectable Malignant Solid Neoplasm · Metastatic Malignant Solid Neoplasm

#MetastaticMalignantSolidNeoplasm#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2

임상시험 7상태 DISCONTINUED

ADCBiologicstaleRemeGen Co., Ltd.Phase 3

disitamab vedotin (Disitamab Vedotin, RC48, RC48-ADC（2.5mg/kg）)

Gastric Cancer · Gastric Cancer

#GastricCancer#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+1

임상시험 7상태 RECRUITING

CGTBiologicstaleMiltenyi Biomedicine GmbHPhase 2

MB-CART19.1 (MB-CART19.1)

Precursor B-Lymphoblastic Lymphoma/Leukaemia Refractory · Melanoma Stage III

#MelanomaStageIII#CGT#Phase2#세포유전치료#CAR-T+4

임상시험 7상태 ACTIVE

AntibodystaleBristol Myers SquibbPhase 2

nivolumab (Opdivo, Nivolumab Injection [Opdivo])

Advanced Cancer; Gastric Cancer · Malignant Melanoma

#MalignantMelanoma#Antibody#Phase2#항체#면역항체+4

임상시험 7상태 RECRUITING

AntibodystaleARCAGYPhase 2

Ubamatamab (Ubamatamab)

Ovarian Cancer · Recurrent Ovarian Cancer

#RecurrentOvarianCancer#Antibody#Phase2#항체#면역항체+3

임상시험 7상태 RECRUITING

CGTBiologicstaleTILT Biotherapeutics Ltd.Phase 2

TILT-123 (TILT-123)

Melanoma; Head and Neck Squamous Cell Carcinoma · Melanoma

#Melanoma#CGT#Phase2#세포유전치료#CAR-T+3

임상시험 6상태 RECRUITING

ADCBiologicstaleNeogap Therapeutics ABPhase 1

LNL (Tumor-draining lymph node-derived lymphocyte, Tumor-draining lymph node-derived lymphocyte (LNL))

Breast Neoplasms · Breast Neoplasms

#BreastNeoplasms#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1

임상시험 6상태 RECRUITING

ADCBiologicstaleAbbViePhase 3

Mirvetuximab soravtansine plus Bevacizumab (Mirvetuximab soravtansine plus Bevacizumab)

Ovarian Cancer; Peritoneal Cancer · Ovarian Cancer

#OvarianCancer#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2

효능 ORR 100%임상시험 6상태 RECRUITING

40 / 167 페이지

← 이전 다음 →

전체 9,268개 프로그램 보기

갱신 기록 없음 · 14일 주기 · 방문 0 / 572

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

추천 비교

최근 활동

빠른 검색 · 이슈 태그

Rucaparib Camsylate (Rucaparib Camsylate)

trastuzumab vc-seco-DUBA (SYD985, SYD985 (trastuzumab vc-seco-DUBA))

Lorvotuzumab Mertansine (Lorvotuzumab Mertansine)

SYD985 (SYD985)

Emactuzumab (Emactuzumab)

JS212 (JS212)

MEDI4736 (Durvalumab, Durvalumab (MEDI4736))

atezolizumab (Tecentriq, Atezolizumab and Recombinant Human Hyaluronidase)

[vic-]trastuzumab duocarmazine (SYD985, SYD985 ([vic-]trastuzumab duocarmazine))

GSK2857916 with Pomalidomide and Dexamethasone (GSK2857916 with Pomalidomide and Dexamethasone)

HLX22 (HLX22)

Raludotatug deruxtecan (Raludotatug deruxtecan)

Cetuximab/Erbitux (Cetuximab/Erbitux)

MT027 (MT027)

trastuzumab (Herceptin, SYD985, Vic-trastuzumab duocarmazine, Vic-trastuzumab duocarmazine (SYD985) + paclitaxel)

ATLCAR.CD30 T cells (ATLCAR.CD30 T cells)

anti-MUC1 CAR-T cells (anti-MUC1 CAR-T cells)

Neratinib Maleate (Neratinib Maleate)

disitamab vedotin (Disitamab Vedotin, RC48, RC48-ADC（2.5mg/kg）)

MB-CART19.1 (MB-CART19.1)

nivolumab (Opdivo, Nivolumab Injection [Opdivo])

Ubamatamab (Ubamatamab)

TILT-123 (TILT-123)

LNL (Tumor-draining lymph node-derived lymphocyte, Tumor-draining lymph node-derived lymphocyte (LNL))

Mirvetuximab soravtansine plus Bevacizumab (Mirvetuximab soravtansine plus Bevacizumab)

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

추천 비교

최근 활동

빠른 검색 · 이슈 태그

실시간 이슈 · 검색

Rucaparib Camsylate (Rucaparib Camsylate)

trastuzumab vc-seco-DUBA (SYD985, SYD985 (trastuzumab vc-seco-DUBA))

Lorvotuzumab Mertansine (Lorvotuzumab Mertansine)

SYD985 (SYD985)

Emactuzumab (Emactuzumab)

JS212 (JS212)

MEDI4736 (Durvalumab, Durvalumab (MEDI4736))

atezolizumab (Tecentriq, Atezolizumab and Recombinant Human Hyaluronidase)

[vic-]trastuzumab duocarmazine (SYD985, SYD985 ([vic-]trastuzumab duocarmazine))

GSK2857916 with Pomalidomide and Dexamethasone (GSK2857916 with Pomalidomide and Dexamethasone)

HLX22 (HLX22)

Raludotatug deruxtecan (Raludotatug deruxtecan)

Cetuximab/Erbitux (Cetuximab/Erbitux)

MT027 (MT027)

trastuzumab (Herceptin, SYD985, Vic-trastuzumab duocarmazine, Vic-trastuzumab duocarmazine (SYD985) + paclitaxel)

ATLCAR.CD30 T cells (ATLCAR.CD30 T cells)

anti-MUC1 CAR-T cells (anti-MUC1 CAR-T cells)

Neratinib Maleate (Neratinib Maleate)

disitamab vedotin (Disitamab Vedotin, RC48, RC48-ADC（2.5mg/kg）)

MB-CART19.1 (MB-CART19.1)

nivolumab (Opdivo, Nivolumab Injection [Opdivo])

Ubamatamab (Ubamatamab)

TILT-123 (TILT-123)

LNL (Tumor-draining lymph node-derived lymphocyte, Tumor-draining lymph node-derived lymphocyte (LNL))

Mirvetuximab soravtansine plus Bevacizumab (Mirvetuximab soravtansine plus Bevacizumab)

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

추천 비교

최근 활동

빠른 검색 · 이슈 태그

실시간 이슈 · 검색

Rucaparib Camsylate (Rucaparib Camsylate)

trastuzumab vc-seco-DUBA (SYD985, SYD985 (trastuzumab vc-seco-DUBA))

Lorvotuzumab Mertansine (Lorvotuzumab Mertansine)

SYD985 (SYD985)

Emactuzumab (Emactuzumab)

JS212 (JS212)

MEDI4736 (Durvalumab, Durvalumab (MEDI4736))

atezolizumab (Tecentriq, Atezolizumab and Recombinant Human Hyaluronidase)

[vic-]trastuzumab duocarmazine (SYD985, SYD985 ([vic-]trastuzumab duocarmazine))

GSK2857916 with Pomalidomide and Dexamethasone (GSK2857916 with Pomalidomide and Dexamethasone)

HLX22 (HLX22)

Raludotatug deruxtecan (Raludotatug deruxtecan)

Cetuximab/Erbitux (Cetuximab/Erbitux)

MT027 (MT027)

trastuzumab (Herceptin, SYD985, Vic-trastuzumab duocarmazine, Vic-trastuzumab duocarmazine (SYD985) + paclitaxel)

ATLCAR.CD30 T cells (ATLCAR.CD30 T cells)